PDSB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
PDS Biotechnology Corp (PDSB) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are mixed with bearish moving averages and neutral RSI, while the financial performance shows declining income and EPS. Additionally, there are no significant positive catalysts or trading signals to suggest immediate upside potential.
The MACD is slightly positive and expanding, indicating mild bullish momentum. However, the moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and RSI is neutral at 55.389. Key support is at 0.544, and resistance is at 0.707. The stock's technical setup does not strongly favor a buy.
NULL identified. There is no recent news, no significant insider or hedge fund activity, and no recent congress trading data.
Declining financial performance in 2025/Q3, with net income dropping by -16.01% YoY and EPS decreasing by -34.48% YoY. Additionally, the stock has a historical tendency for minor short-term gains but lacks strong upward momentum.
In 2025/Q3, the company reported no revenue growth (0% YoY), a net income decline of -16.01% YoY to -9,009,411, and a significant drop in EPS by -34.48% YoY to -0.19. Gross margin remained at 0% YoY.
No recent analyst ratings or price target changes are available.
